It has been reported that the inhibition of KCa3.1 reduces macrophage activation and levels of cytokines in the brain, such as IL-1β, suggesting a potential novel association between KCa3.1 and AF (11). This evidence concerns the gene KCNN4 and atrial fibrillation.